Strategies to enhance the effects of pictorial warnings for cigarettes: results from a discrete choice experiment.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
04 2022
Historique:
received: 26 03 2021
accepted: 28 09 2021
pubmed: 27 10 2021
medline: 6 4 2022
entrez: 26 10 2021
Statut: ppublish

Résumé

To measure the effects of changing attributes of pictorial health warning labels (HWLs) on cigarette packs in a country that has already implemented pictorial HWLs. For each choice set, participants were presented with two cigarette packs and asked the following three questions: (1) 'If only these two cigarette packs were available, which would you buy?'; (2) 'Each of these two packs has warnings on the front and back about the health effects of smoking. Which of these warnings best informs you about the dangers from smoking?'; and (3) 'Which warning most makes you think about quitting smoking?'. As recommended for best practices in discrete choice experiments, each of these questions was followed by an 'opt-out' question for participants to indicate whether they really believed there was a difference between the options presented (i.e. 'Would you really choose one of them?'; 'Do you really think that either of these warnings informs you about dangers from smoking?'; or 'Do you really think that either of these warnings would make you think about quitting smoking?', respectively). Each choice set could be viewed for as long as the participant wished. For each choice question (i.e. willingness to buy, informative, motivating to quit), the pack chosen was coded as 1 and the other pack as 0, with both packs being given a value of 0 if the participant 'opted out'. A within-subject discrete choice experiment that involved systematic manipulation of pictorial HWL size [75 versus 30% (current policy)]; inclusion of imagery on the back of the pack [versus none (current policy)]; and color formatting [black on yellow versus yellow on black (current policy)]. Mexico, on-line panel. Adult smokers (n = 705). For each choice set, participants selected one pack as having the most informative HWL about smoking harms, the one that makes them think the most about quitting and the one they were most willing to buy. We assessed the independent and interactive effects of HWL attributes on choices. Larger HWL size on the pack front (75 versus 30%) and inclusion of a pictorial image on the pack back were both independently associated with lower willingness to buy a pack [b = -0.228, standard error (SE) = 0.023 and -0.089, SE = 0.016, respectively] and greater perception of an HWL as informative (b = 0.214, SE = 0.022, and 0.191, SE = 0.017, respectively) and motivating to quit (b = 0.251, SE = 0.023 and 0.194, SE = 0.017, respectively). HWL with black text and yellow background were perceived as less informative (b = -0.037, SE = 0.016) and less motivating to quit (b = -0.032, SE = 0.015) compared with yellow text on a black background. Among adult Mexican smokers, pictorial health warning labels on cigarette packages that are larger or cover both sides of the pack appear more effective at lowering purchase intentions and increasing risk perceptions and motivation to quit than smaller health warning labels or health warning labels with imagery only on the pack front.

Identifiants

pubmed: 34697845
doi: 10.1111/add.15725
pmc: PMC8904287
mid: NIHMS1760636
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1095-1104

Subventions

Organisme : NCI NIH HHS
ID : R01 CA167067
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA215466
Pays : United States
Organisme : FIC NIH HHS
ID : R01 TW010652
Pays : United States

Informations de copyright

© 2021 Society for the Study of Addiction.

Références

Tob Control. 2020 Jul 14;:
pubmed: 32665358
Med Decis Making. 2018 Jan;38(1):120-133
pubmed: 28863752
Tob Control. 2017 Jul;26(4):468-470
pubmed: 27329114
Salud Publica Mex. 2020 Nov-Dec;62(6):820-828
pubmed: 33620978
Tob Control. 2017 May;26(3):307-315
pubmed: 27255118
Tob Regul Sci. 2015 Jul;1(2):175-185
pubmed: 26550583
Salud Publica Mex. 2012 Jun;54(3):254-63
pubmed: 22689163
Nicotine Tob Res. 2016 Sep;18(9):1910-4
pubmed: 27146637
Nicotine Tob Res. 2018 Jun 7;20(7):888-896
pubmed: 28637294
Addict Behav. 2019 May;92:64-68
pubmed: 30597332
Nicotine Tob Res. 2007 Apr;9(4):473-81
pubmed: 17454702
Health Educ Res. 2015 Feb;30(1):35-45
pubmed: 24848554
Soc Sci Med. 2016 Sep;164:118-129
pubmed: 27423739
Cancer Causes Control. 2012 Mar;23 Suppl 1:69-80
pubmed: 22350859
PLoS One. 2013;8(1):e52206
pubmed: 23341895
Health Policy. 2011 Sep;102(1):41-8
pubmed: 21763026
Nicotine Tob Res. 2019 Jun 21;21(7):887-895
pubmed: 30452728
Tob Regul Sci. 2018 Mar;4(2):73-87
pubmed: 30828595
Tob Control. 2006 Jun;15 Suppl 3:iii19-25
pubmed: 16754942
J Calif Dent Assoc. 2016 Oct;44(10):633-640
pubmed: 28190943
BMC Public Health. 2015 Mar 13;15:240
pubmed: 25880278
J Health Commun. 2013;18(10):1180-92
pubmed: 23905611
Pharmacoeconomics. 2013 Apr;31(4):345-55
pubmed: 23516033
Patient. 2019 Feb;12(1):137-148
pubmed: 30367434
Am J Prev Med. 2012 Dec;43(6):590-600
pubmed: 23159254
Tob Control. 2011 Sep;20(5):327-37
pubmed: 21606180
Pharmacoecon Open. 2018 Mar;2(1):5-17
pubmed: 29464666
PLoS One. 2019 Oct 23;14(10):e0224217
pubmed: 31644598
Cancer Causes Control. 2012 Mar;23 Suppl 1:57-67
pubmed: 22362058
Tob Control. 2021 May;30(3):305-311
pubmed: 32381679
Soc Sci Med. 2016 Sep;164:141-149
pubmed: 26092600
Nicotine Tob Res. 2016 May;18(5):1348-56
pubmed: 26014454
Tob Control. 2016 May;25(3):341-54
pubmed: 25948713
Value Health. 2017 Jul - Aug;20(7):969-975
pubmed: 28712627
Am J Prev Med. 2011 Jun;40(6):674-82
pubmed: 21565661
Addiction. 2012 Jun;107(6):1159-67
pubmed: 22372966
Drug Alcohol Depend. 2019 May 1;198:87-94
pubmed: 30889524
Nicotine Tob Res. 2019 Jun 21;21(7):855-862
pubmed: 29444268
PLoS One. 2015 Dec 16;10(12):e0142879
pubmed: 26672982
Tob Control. 2013 May;22(e1):e57-65
pubmed: 22752271
Nicotine Tob Res. 2018 Jun 7;20(7):859-866
pubmed: 29126207
Nicotine Tob Res. 2016 May;18(5):1376-81
pubmed: 26377516

Auteurs

James F Thrasher (JF)

Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Department of Tobacco Research, Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.

Farahnaz Islam (F)

Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Edna Arillo-Santillán (E)

Department of Tobacco Research, Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.

Rosibel Rodriguez-Bolaños (R)

Department of Tobacco Research, Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.

Belen Saenz de Miera Juarez (B)

Department of Economics, Autonomous University of Baja California Sur, La Paz, Mexico.

James W Hardin (JW)

Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Inti Barrientos-Gutierrez (I)

Evaluation and Surveys Research Center, National Institute of Public Health, Mexico City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH